309 related articles for article (PubMed ID: 30194636)
21. An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia.
Wenzler E; Wang F; Goff DA; Prier B; Mellett J; Mangino JE; Bauer KA
Clin Infect Dis; 2017 Jul; 65(2):194-200. PubMed ID: 28379326
[TBL] [Abstract][Full Text] [Related]
22. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
[TBL] [Abstract][Full Text] [Related]
23. Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System.
Turner RB; Valcarlos E; Won R; Chang E; Schwartz J
Antimicrob Agents Chemother; 2016 Oct; 60(10):5682-7. PubMed ID: 27401580
[TBL] [Abstract][Full Text] [Related]
24. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
[TBL] [Abstract][Full Text] [Related]
25. Association of Infectious Diseases Consultation With Long-term Postdischarge Outcomes Among Patients With Staphylococcus aureus Bacteremia.
Goto M; Jones MP; Schweizer ML; Livorsi DJ; Perencevich EN; Richardson K; Beck BF; Alexander B; Ohl ME
JAMA Netw Open; 2020 Feb; 3(2):e1921048. PubMed ID: 32049296
[TBL] [Abstract][Full Text] [Related]
26. Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review.
Buehrle K; Pisano J; Han Z; Pettit NN
Am J Infect Control; 2017 Jul; 45(7):713-716. PubMed ID: 28431847
[TBL] [Abstract][Full Text] [Related]
27. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
[TBL] [Abstract][Full Text] [Related]
28. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
[TBL] [Abstract][Full Text] [Related]
29. Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.
Goto M; Schweizer ML; Vaughan-Sarrazin MS; Perencevich EN; Livorsi DJ; Diekema DJ; Richardson KK; Beck BF; Alexander B; Ohl ME
JAMA Intern Med; 2017 Oct; 177(10):1489-1497. PubMed ID: 28873140
[TBL] [Abstract][Full Text] [Related]
30. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia.
Jenkins TC; Price CS; Sabel AL; Mehler PS; Burman WJ
Clin Infect Dis; 2008 Apr; 46(7):1000-8. PubMed ID: 18444816
[TBL] [Abstract][Full Text] [Related]
31. Impact of Infectious Diseases Consultation on Management and Outcome of Staphylococcus aureus Bacteremia in Children.
Duguid RC; Al Reesi M; Bartlett AW; Palasanthiran P; McMullan BJ
J Pediatric Infect Dis Soc; 2021 May; 10(5):569-575. PubMed ID: 33355663
[TBL] [Abstract][Full Text] [Related]
32. Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics.
Ruotsalainen E; Kardén-Lilja M; Kuusela P; Vuopio-Varkila J; Virolainen-Julkunen A; Sarna S; Valtonen V; Järvinen A
J Infect; 2008 Apr; 56(4):249-56. PubMed ID: 18314197
[TBL] [Abstract][Full Text] [Related]
33. Changes in hemostasis parameters in nonfatal methicillin-sensitive Staphylococcus aureus bacteremia complicated by endocarditis or thromboembolic events: a prospective gender-age adjusted cohort study.
Forsblom E; Lepäntalo A; Wartiovaara-Kautto U; Ruotsalainen E; Järvinen A
APMIS; 2019 Jul; 127(7):515-528. PubMed ID: 31009118
[TBL] [Abstract][Full Text] [Related]
34. Factors for mortality in patients with persistent Staphylococcus aureus bacteremia: The importance of treatment response rather than bacteremia duration.
Kim SH; Jeon M; Jang S; Mun SJ
J Microbiol Immunol Infect; 2023 Oct; 56(5):1007-1015. PubMed ID: 37580183
[TBL] [Abstract][Full Text] [Related]
35. Impact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management.
Kufel WD; Mastro KA; Steele JM; Wang D; Riddell SW; Paolino KM; Thomas SJ
Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115535. PubMed ID: 34634714
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
Trials; 2019 May; 20(1):250. PubMed ID: 31046810
[TBL] [Abstract][Full Text] [Related]
37.
Berrevoets MAH; Kouijzer IJE; Slieker K; Aarntzen EHJG; Kullberg BJ; Oever JT; Bleeker-Rovers CP
J Nucl Med; 2019 Jul; 60(7):998-1002. PubMed ID: 30552202
[TBL] [Abstract][Full Text] [Related]
38. Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease.
Kang CK; Kwak YG; Park Y; Song KH; Kim ES; Jung SI; Park KH; Park WB; Kim NJ; Kim YK; Jang HC; Lee S; Jeon JH; Kwon KT; Kim CJ; Kim YS; Kim HB;
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1119-1123. PubMed ID: 29667110
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.
Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Gao W; Christiansen KJ; Coombs GW; Johnson PD; Howden BP
J Infect Dis; 2011 Aug; 204(3):340-7. PubMed ID: 21742831
[TBL] [Abstract][Full Text] [Related]
40. [Staphylococcus aureus bacteremia - a distinct entity].
Weis S; Kaasch AJ; Rieg S; Löffler B; Hagel S; Forstner C; Brunkhorst FM; Pletz MW
Dtsch Med Wochenschr; 2015 Jun; 140(13):982-9. PubMed ID: 26115133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
